|4Jul 27, 7:19 PM ET

Lazarus Macro Micro Partners LLLP 4

4 · Aeon Global Health Corp. · Filed Jul 27, 2020

Insider Transaction Report

Form 4
Period: 2020-07-09
Transactions
  • Sale

    Common Stock

    2020-07-09$0.07/sh18,276$1,188168,468 total(indirect: By: Ibex Microcap Fund LLLP)
  • Sale

    Common Stock

    2020-07-21$0.07/sh5,500$413162,968 total(indirect: By: Ibex Microcap Fund LLLP)
  • Sale

    Common Stock

    2020-07-24$0.07/sh10,000$750152,968 total(indirect: By: Ibex Microcap Fund LLLP)
Holdings
  • Common Stock

    (indirect: By: Lazarus Macro Micro Partners LLLP)
    833
Footnotes (3)
  • [F1]These securities reported herein are owned directly by Ibex Microcap Fund LLLP ("Ibex Microcap"). Ibex Investors LLC ("Ibex") is the investment dviser and general partner of Ibex Microcap and Justin B. Borus is the manager of Ibex.
  • [F2]These securities reported herein are owned directly by Lazarus Macro Micro Partners LLLP ("Macro Micro"). Ibex is the investment adviser and general partner of Macro Micro.
  • [F3]Each of Ibex and Mr. Borus expressly disclaims beneficial ownership of the securities held by Ibex Microcap and Macro Micro (referred to collectively as the "Funds") except to the extent of his or its pecuniary interest therein, if any. Each of the Funds expressly disclaims beneficial ownership of the securities held by the other Fund. The filing of this Form 4 shall not be construed as an admission that either Ibex or Mr. Borus (or each Fund with respect to the securities held by the other Fund), for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein.

Documents

1 file
  • 4
    ownership.xmlPrimary